Supernus Pharmaceuticals Fundamental Score
Supernus Pharmaceuticals Fundamental Score Chart
Supernus Pharmaceuticals Historical Fundamental Score DataPro Data Export
There is no data for the selected date range.
About Fundamental Score
The fundamental score is YCharts proprietary score of how strong a company's fundamentals are. It ranges from 1 to 10, with 10 being the strongest. The ten tests are as follows (score one point for each test the company passes):
1) EPS Growth > 0
2) Revenue Growth > 0
3) Five Year Average ROE > 5%
4) 10 Year Minimum Gross Margin > 0
5) Book Value Per Share Growth > 0
6) Current Ratio > 1
7) Debt to Equity Ratio < 13
8) 10 Year Average Cash Flow > 0
9) Long Term Debt < 5 x Net Income
10) Uninterrupted dividend payments as far back as we have data
(unless otherwise noted, growth rates are calculated for 10 years or the life of the stock, whichever is shorter)
Further details can be found in our support center article about the fundamental score.
View Fundamental Score for SUPN.
Start Your YCharts Pro Gold Membership.
Access over 100 stock metrics like Beta, EV/EBITDA, PE10, Free Cash Flow Yield, KZ Index and Cash Conversion Cycle.
YCharts Pro is only $49/month, and comes with a 14-day free trial.Get Started Now
Already a YCharts Pro Gold Member? Sign in here.
SUPN Fundamental Score Benchmarks
|Pernix Therapeutics||Go Pro|
|Catalyst Pharmaceutical Partners||Go Pro|
|Lannett Company||Go Pro|
SUPN Fundamental Score Rankings
3721 of 7600
374 of 653 in Healthcare
42 of 66 in Drug Manufacturers - Specialty & Generic
SUPN Fundamental Score Range, Past 5 Years
|Minimum||Go Pro||Dec 2012|
|Maximum||Go Pro||Dec 2012|
GlobeNewswire May 20
Street Insider May 17